Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,043 | 178 | 96.1% |
| Unspecified | $109.50 | 1 | 3.5% |
| Education | $14.42 | 3 | 0.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $535.25 | 33 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $506.68 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $274.77 | 12 | $0 (2021) |
| Lilly USA, LLC | $246.93 | 16 | $0 (2023) |
| Novo Nordisk Inc | $221.36 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $200.72 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $158.13 | 9 | $0 (2024) |
| AbbVie Inc. | $117.58 | 6 | $0 (2021) |
| Eli Lilly and Company | $109.50 | 1 | $0 (2024) |
| PFIZER INC. | $104.82 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $233.83 | 7 | Eli Lilly and Company ($109.50) |
| 2023 | $59.46 | 3 | GlaxoSmithKline, LLC. ($31.84) |
| 2022 | $29.38 | 2 | Novo Nordisk Inc ($29.38) |
| 2021 | $314.32 | 16 | Janssen Pharmaceuticals, Inc ($100.18) |
| 2020 | $388.88 | 19 | AstraZeneca Pharmaceuticals LP ($130.49) |
| 2019 | $802.50 | 50 | Amgen Inc. ($199.55) |
| 2018 | $700.44 | 44 | Amgen Inc. ($171.01) |
| 2017 | $638.08 | 41 | Amgen Inc. ($121.98) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | Eli Lilly and Company | — | — | In-kind items and services | $109.50 | Research |
| Study: LONG-TERM REAL-WORLD COMPARATIVE EFFECTIVENESS OF DONANEMAB PLUS USUAL CARE VERSUS USUAL CARE ALONE IN US PATIENTS WITH EARLY SYMPTOMATIC ALZHEIMER'S DISEASE (TRAILBLAZER-REAL US) | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: VACCINE | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: DIABETES | ||||||
| 06/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.73 | General |
| 06/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Diabetes | ||||||
| 06/08/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: VACCINES | ||||||
| 12/02/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.85 | General |
| 05/14/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.53 | General |
| 10/17/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Diabetes | ||||||
| 07/19/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/09/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: DIABETES | ||||||
| 07/01/2021 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 06/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/15/2021 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 06/04/2021 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT (Biological), VAXELIS, MENACTRA | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Vaccines | ||||||
| 04/26/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Cardiovascular | ||||||
| 04/23/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 04/22/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LONG-TERM REAL-WORLD COMPARATIVE EFFECTIVENESS OF DONANEMAB PLUS USUAL CARE VERSUS USUAL CARE ALONE IN US PATIENTS WITH EARLY SYMPTOMATIC ALZHEIMER'S DISEASE (TRAILBLAZER-REAL US) | Eli Lilly and Company | $109.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 460 | 533 | $107,473 | $38,695 |
| 2022 | 11 | 596 | 708 | $111,229 | $48,406 |
| 2021 | 8 | 621 | 742 | $112,374 | $47,668 |
| 2020 | 10 | 619 | 736 | $107,805 | $40,397 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 135 | 135 | $34,560 | $17,616 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 133 | $44,673 | $11,032 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 95 | $22,140 | $5,560 | 25.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 130 | 130 | $3,900 | $2,438 | 62.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 20 | $1,500 | $1,425 | 95.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $700.00 | $623.20 | 89.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 135 | 135 | $34,560 | $17,951 | 51.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 183 | $43,920 | $14,413 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 94 | $15,228 | $4,830 | 31.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 39 | 39 | $2,925 | $2,660 | 90.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 133 | 133 | $3,990 | $2,487 | 62.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $3,960 | $1,874 | 47.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $1,875 | $1,846 | 98.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 40 | $1,400 | $1,208 | 86.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 22 | $2,156 | $627.23 | 29.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 15 | $900.00 | $454.27 | 50.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 13 | 21 | $315.00 | $54.73 | 17.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 134 | 134 | $34,348 | $18,148 | 52.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 118 | 196 | $47,040 | $16,246 | 34.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 90 | 118 | $19,116 | $6,291 | 32.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 46 | 46 | $2,725 | $2,665 | 97.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 133 | 133 | $3,990 | $2,540 | 63.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 29 | 30 | $2,940 | $851.91 | 29.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 47 | 47 | $1,645 | $800.96 | 48.7% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 24 | 38 | $570.00 | $126.40 | 22.2% |
About Dr. David Lindstrom, MD
Dr. David Lindstrom, MD is a Family Medicine healthcare provider based in Everett, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902852569.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lindstrom, MD has received a total of $3,167 in payments from pharmaceutical and medical device companies, with $233.83 received in 2024. These payments were reported across 182 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,043).
As a Medicare-enrolled provider, Lindstrom has provided services to 2,296 Medicare beneficiaries, totaling 2,719 services with total Medicare billing of $175,166. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Everett, WA
- Active Since 05/25/2006
- Last Updated 01/11/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902852569
Products in Payments
- XARELTO (Drug) $274.77
- Aimovig (Biological) $224.57
- BEVESPI AEROSPHERE (Drug) $219.35
- Prolia (Biological) $172.07
- TRULICITY (Drug) $164.16
- JARDIANCE (Drug) $153.11
- FARXIGA (Drug) $152.78
- Ozempic (Drug) $117.67
- CHANTIX (Drug) $93.34
- SYMBICORT (Drug) $75.17
- SOLIQUA (Drug) $69.34
- Repatha (Biological) $66.59
- EMGALITY (Drug) $55.15
- AJOVY (Drug) $48.64
- Vascepa (Drug) $43.39
- EVENITY (Biological) $43.26
- ELIQUIS (Drug) $37.21
- PEDIARIX (Biological) $36.79
- BEXSERO (Biological) $33.78
- SHINGRIX (Biological) $30.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Everett
Dr. Simi Kohli, M.d., M.sc, M.D., M.SC
Family Medicine — Payments: $4,866
Albert Yuen, Md, MD
Family Medicine — Payments: $3,915
Dr. Donald Ebersole, Md, MD
Family Medicine — Payments: $3,520
Dr. Vincent Koike, D.o, D.O
Family Medicine — Payments: $3,241
Dr. Tushar Garg, Do, DO
Family Medicine — Payments: $1,849
Sara Nelson, Md, MD
Family Medicine — Payments: $1,466